We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides.
- Authors
Papadavid, Evangelia; Antoniou, Christina; Nikolaou, Vassiliki; Siakantaris, Marina; Vassilakopoulos, Theodoros P; Stratigos, Alexandros; Stavrianeas, Nikolaos; Katsambas, Andreas
- Abstract
The new rexinoid bexarotene is a retinoid X receptor antagonist and immune response modifier. Although combinations of oral bexarotene and psoralen plus UVA (PUVA) have been tried in patients with all stages of mycosis fungoides (MF), the dosage of bexarotene used in these combination regimens has been variable.
- Publication
American journal of clinical dermatology, 2008, Vol 9, Issue 3, p169
- ISSN
1175-0561
- Publication type
Journal Article
- DOI
10.2165/00128071-200809030-00005